Home › Funds › Principal Global Investors › RGEN
Principal Global Investors position in RGEN
REPLIGEN CORP · Health Care
Latest position (Q2 2026)120.38K sh
Reported value held$16.43M
Portfolio Weight0.01%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 178.34K | $51.54M | New |
| Q4 2021 | 191.11K | $50.61M | Add |
| Q1 2022 | 175.25K | $32.96M | Reduce |
| Q2 2022 | 204.67K | $33.24M | Add |
| Q3 2022 | 203.28K | $38.03M | Reduce |
| Q4 2022 | 204.10K | $34.56M | Hold |
| Q1 2023 | 204.97K | $34.51M | Hold |
| Q2 2023 | 195.82K | $27.70M | Reduce |
| Q3 2023 | 192.68K | $30.64M | Reduce |
| Q4 2023 | 262.71K | $47.23M | Add |
| Q1 2024 | 345.44K | $63.53M | Add |
| Q2 2024 | 173.43K | $21.86M | Reduce |
| Q3 2024 | 120.99K | $18.01M | Reduce |
| Q4 2024 | 119.91K | $17.26M | Reduce |
| Q1 2025 | 186.72K | $23.76M | Add |
| Q2 2025 | 118.61K | $14.75M | Reduce |
| Q3 2025 | 117.43K | $15.70M | Reduce |
| Q4 2025 | 198.20K | $32.48M | Add |
| Q1 2026 | 159.75K | $18.82M | Reduce |
| Q2 2026 | 120.38K | $16.43M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding RGEN
- Vanguard Group 4.99M sh · $818.31M · Q4 2025
- Maverick Capital 1.98M sh · $270.77M · Q2 2026
- MFS Investment Management 1.62M sh · $220.61M · Q2 2026
- Invesco Ltd 1.39M sh · $189.28M · Q2 2026
- Geode Capital Management 1.06M sh · $145.00M · Q2 2026
- UBS Group AG 795.01K sh · $108.47M · Q2 2026
- Baron Funds 748.47K sh · $102.12M · Q2 2026
- Norges Bank Investment Management 575.23K sh · $78.48M · Q2 2026
- Charles Schwab Investment Management 481.74K sh · $65.73M · Q2 2026
- Northern Trust Corp 444.15K sh · $60.60M · Q2 2026
- Citadel Advisors 427.11K sh · $58.27M · Q2 2026
- Bank of America Corp 426.29K sh · $58.16M · Q2 2026